Chinese biotech company: COVID-19 vaccine effective in treating multiple strains of virus


FIL – This Thursday, Jan. 23. 2020 from file photo, a patient receives a flu vaccine in Mesquite, Texas. (AP Photo / LM Otero)

TO Newsroom
UPDATED 11:45 AM PT – Saturday 22 August 2020

A biotech company in China has claimed that its new vaccine for coronavirus is effective in treating multiple strains of the virus. Sinovac Biotech announced the development on Friday.

Officials said the vaccine they are developing could neutralize the virus in different strains from around the world. The company has sworn to share its findings and vaccines with the countries that consider China “in need” when the serum comes off the assembly.

China has worked to limit the presence of the virus in the country.

‘As you know, we have had infected cases from abroad since April. They showed symptoms in China, but were infected in various places around the world, not in China. We got more than 20 different virus strains from them, including those from the United States, Europe, and various Middle Eastern countries. Then we used the immune serum of our vaccine to neutralize these virus strains. ” – Yin Weidong, CEO of Sinovac Biotech

The company has said it can produce 300 million doses of the vaccine each year and has already reached an agreement to supply Indonesia.

MORE NEWS: President Trump: Elderly, Most Vulnerable to Receive COVID-19 Fax First